Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Winblad
B
B
Department of Geriatric Medicine, Karolinska Institute, Huddinge Hospital, Sweden.
Hill
S
S
Beermann
B
B
Post
S G
SG
Wimo
A
A
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics; D002986:Clinical Trials as Topic / Q000191:economics; D003362:Cost-Benefit Analysis; D003431:Cross-Cultural Comparison; D003704:Dementia / Q000188:drug therapy* / Q000191:economics; D016527:Drug Costs; D005060:Europe; D005544:Forecasting; D017048:Health Care Costs / Q000639:trends; D006801:Humans; D007391:International Cooperation; D018697:Nootropic Agents / Q000191:economics* / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome; D014481:United States
D018697:Nootropic Agents